Weekly Tactical Pick: IPCA Labs – Outperforms in domestic formulations market

Trading Calls - Equity F&O

Ipca’s domestic secondary sales are about 12 percent for the quarter gone by. This is in line with management’s guidance for H2 FY21

Moneycontrol Research